What makes BPC-157 distinctive among research peptides is a combination of three properties rarely found together: it has no sequence homology to any other known peptide, it is completely stable in human gastric acid for at least 24 hours (unlike most growth factors and peptide analogues, which are rapidly degraded), and it remains active across an exceptionally broad effective dose range from nanogram to microgram per kilogram bodyweight in pre-clinical models without any known toxic dose having been established in animal studies to date
Advantage: BPC-157 for rapid, targeted results
S.Vilar BarbosaN
What the evidence supports today is biological plausibility worth a proper trial
Le COA est publi, pas promis
(The 503A Bulks List is a list of drug substances that the FDA has approved for compounding.) The committee recommended six of those peptidesBPC-157, KPV, TB-500, MOTS-c, Epitalon, and Semaxbe moved onto the list so that they can be legally prescribed and compounded in the future